Skip to main content

Table 2 The values of coronary flow rate (ml/min) in the experimental groups

From: Myocardial protection against global ischemia with Krebs-Henseleit buffer-based cardioplegic solution

Groups

Baseline

Reperfusion, min

  

5

30

60

120

CON-22 (n=7)

11.9±2.3

3.8±1.5

5.4±1.6

6.5±1.9

5.8±2.6

mKHB-22 (n=7)

10.2±2.6

4.5±2.3

6.7±1.6

6.1±1.8

4.2±1.7

STH2-22 (n=6)

13.2±3.5

5.3±2.5

6.7±2.2

7.5±4.6

5.5±2.1

CON-37 (n=7)

12.4±3.2

4.1±1.3

4.3±1.9

4.1±1.7

3.8±1.2

mKHB-37 (n=5)

10.4±1.9

6.6±4.0

6.2±1.7

6.3±0.6

5.2±1.4

STH2-37 (n=6)

11.2±1.8

5.6±3.9

4.6±2.1

3.3±0.7

3.1±0.9

  1. Data are mean ± SD. Group legends in hypothermia series: controls subjected to 180-min ischemia and 120-min reperfusion (CON-22), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-22), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-22). Group legends in normothermia series: controls subjected to 60-min ischemia and 120-min reperfusion (CON-37), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-37), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-37).